SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 102 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $36,766,000 | +31.8% | 2,454,318 | +7.1% | 0.01% | +33.3% |
| Q1 2016 | $27,886,000 | -22.9% | 2,291,406 | +0.8% | 0.01% | -25.0% |
| Q4 2015 | $36,153,000 | +4.8% | 2,272,375 | +0.9% | 0.01% | -11.1% |
| Q3 2015 | $34,508,000 | -34.0% | 2,251,027 | +4.7% | 0.01% | -30.8% |
| Q2 2015 | $52,260,000 | +8.0% | 2,149,752 | +3.3% | 0.01% | +8.3% |
| Q1 2015 | $48,369,000 | +1.2% | 2,080,406 | +9.3% | 0.01% | 0.0% |
| Q4 2014 | $47,791,000 | -11.7% | 1,903,269 | +9.4% | 0.01% | -20.0% |
| Q3 2014 | $54,127,000 | +41.9% | 1,740,408 | +18.0% | 0.02% | +36.4% |
| Q2 2014 | $38,155,000 | +89.9% | 1,475,464 | +71.6% | 0.01% | +83.3% |
| Q1 2014 | $20,091,000 | -4.4% | 859,709 | +3.9% | 0.01% | 0.0% |
| Q4 2013 | $21,008,000 | +113.3% | 827,737 | +71.5% | 0.01% | +100.0% |
| Q3 2013 | $9,847,000 | +24.2% | 482,683 | +27.7% | 0.00% | 0.0% |
| Q2 2013 | $7,928,000 | – | 377,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |